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G-protein coupled receptors (GPCRs) are a major family of membrane receptors in eukaryotic cells. They play a crucial role
in the communication of a cell with the environment. Ligands bind to GPCRs on the outside of the cell, activating them by
causing a conformational change, and allowing them to bind to G-proteins. Through their interaction with G-proteins,
several effector molecules are activated leading to many kinds of cellular and physiological responses. The great import-
ance of GPCRs and their corresponding signal transduction pathways is indicated by the fact that they take part in many
diverse disease processes and that a large part of efforts towards drug development today is focused on them. We present
Human-gpDB, a database which currently holds information about 713 human GPCRs, 36 human G-proteins and 99 human
effectors. The collection of information about the interactions between these molecules was done manually and the
current version of Human-gpDB holds information for about 1663 connections between GPCRs and G-proteins and
1618 connections between G-proteins and effectors. Major advantages of Human-gpDB are the integration of several
external data sources and the support of advanced visualization techniques. Human-gpDB is a simple, yet a powerful tool
for researchers in the life sciences field as it integrates an up-to-date, carefully curated collection of human GPCRs,
G-proteins, effectors and their interactions. The database may be a reference guide for medical and pharmaceutical
research, especially in the areas of understanding human diseases and chemical and drug discovery.
Database URLs: http://schneider.embl.de/human_gpdb; http://bioinformatics.biol.uoa.gr/human_gpdb/
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Background
Signal transduction refers to these cellular processes by
which stimuli, either physical or chemical, induce specific
cellular responses, through chosen molecular mechanisms.
The specificity of a cellular response to a signal depends on
the receptor expressed on the target cell.
G-protein coupled receptors (GPCRs) are a very import-
ant superfamily of cell membrane receptors in eukaryotic
cells. They may interact with both the environment outside
and inside the cell and they play a crucial role in receiving
stimuli signals from the environment. In response they in-
duce certain cellular responses. GPCRs have a characteristic
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a-helices, an extracellular N terminus, an intracellular C ter-
minus and three interhelical loops on each side of the mem-
brane (1). Several classification systems have been used for
this superfamily categorization. The most frequently system
used (2,3) classifies GPCRs in six classes, based on their
sequence homology and their functional similarity. These
are: Class A or 1 Rhodopsin-like, Class B or 2 Secretin recep-
tor family, Class C or three Metabotropic glutamate/
pheromone, Class D or four Fungal mating pheromone re-
ceptors, Class E or five Cyclic AMP receptors and Class F or
six Frizzled/Smoothened like, first presented by (4). GPCRs
that are not yet characterized or classified are called
orphan GPCRs. Furthermore, a number of putative classes
of some newly discovered GPCRs exist, whose nomenclature
has not yet been accepted by the scientific community (5,6).
Ligands bind to GPCRs on the outside of the cell, activating
the GPCRs by causing a conformational change, and allow-
ing them to bind to G-proteins (7).
G-proteins form heterotrimers composed of Ga,G b and
Gg subunits, which possess a binding site for a GTP or a GDP
molecule. They are characterized by their a-subunits, which
are further grouped into the Gas, Gai/o, Gaq and Ga12
families (8). The stimulation of GPCRs leads to the activa-
tion of G-proteins, which dissociate into their Ga and Gbg
subunits. The subunits then activate several effector mol-
ecules that lead to many kinds of cellular and physiological
responses (1). Effectors form a diverse group of proteins
through their interaction with G-proteins that act either
as secondary messengers, or lead directly to a cellular and
physiological response. Many proteins such as tubulins, ad-
enylate cyclases, ion channels and others act as effectors (5).
GPCRs, G-proteins, effectors and their interactions compose
one of the main mechanisms for signal transduction and
activation or deactivation of pathways within the cell. A
large part of efforts towards drug development today is
focused on finding chemicals that affect the ability of lig-
ands to bind to GPCRs (9) either to inhibit or accelerate
certain cellular processes. GPCRs play a crucial role in a
wide range of human diseases.
Human-gpDB was developed as a tool for integrating
together human GPCRs, G-proteins and effectors. It does
not only present how they interact with each other but it
also reveals information about the pathways they are
involved in. Human-gpDB was built as a useful tool for
drug research and as a platform that reveals new patterns
for therapeutic paths.
Construction and content
Data integration
Our initial step was to collect sequence information indi-
vidually about human GPCRs, G-proteins and effectors from
the UniProt/Swissprot database (10). The entries were
acquired using suitable scripts written in Perl in order to
parse the DE (description), the GN (gene) or the DR (data-
base cross reference) field of a respective database entry.
The data sets were then checked manually in order to elim-
inate duplicates. Our main goal was to include database
unique entries from UniProt/SwissProt. Perl scripts were
used for data manipulation.
For each of the three sets, the next step was to isolate
and keep these proteins that have at least one connection
with another protein, a GPCR with a G-protein and a
G-protein with an effector and vice versa. For the extrac-
tion of information concerning the connections between
human GPCRs, G-proteins and effectors, an extensive litera-
ture search was performed attempting to detect terms that
co-occur in the same abstract and are biologically related.
None of the available text mining engines was used in
order to avoid false negative results and to increase the
reliability of the results that are presented. Currently the
database holds 1663 connections between GPCRs and
G-proteins and 1618 connections between G-proteins and
effectors. In addition, PubMed reference articles that pro-
vide the literature support for each recorded connection
are included.
Efficient ways were used to show how G-proteins and
effectors might be categorized into families, subfamilies
and types. G-proteins’ classification is the most commonly
used and is based on their a subunits sequence homology,
while effectors’ classification is based on their function.
Many different classifications exist regarding GPCRs; the
classification used here was according to the IUPHAR clas-
sification (2). All classifications were done manually.
UniProt (10) identifiers were used as starting points to
integrate the Human-gpDB with various external data
sources. The systems that were used to help us with this
integration were ENSEMBL (11), BioMart (12) and SRS
(13). For each of the proteins, information about the
name, the sequence, the description, the family and the
subfamily it belongs to, together with the full record
coming from the Dasty2 DAS client (14) was collected.
Furthermore, a collection of a vast variety of linked identi-
fiers was obtained, to enrich the information for each pro-
tein. Thus, information comes from various databases like
for example Uniprot (10), RefSeq Proteins (15), Entrez
Proteins (16) and Ensembl Proteins databases (11).
Information about the gene location and its properties
are provided from Ensembl (11), EMBL (17), EntrezGene
(18), RefSeq DNA (15) and UniGene databases. Domain
links are provided for Smart (19), InterPro (20) and Pfam
(21,22) databases. Structures are linked to PDB (23), HSSP
(24) and PSSH (25) databases. Information about diseases
comes from the OMIM (26) database and information
about protein function from the Gene Ontology (27) data-
base. Chemical information is provided by HMDB (28) and
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(30), Panther (31) and Reactome (32) databases. Drugs
related to three categories of molecules of Human-gpDB
(GPCRs, G-proteins, effectors) were collected from
DrugBank (29), Madator (33) and AKS2 (34). All available
interactions between drugs and the three categories of
molecules of the database are presented to the user using
visualization tools (see ‘Visualization’ section for more de-
tails). All of the aforementioned information was collected
for each protein using ENSEMBL, BioMart and SRS and the
results were stored in a MySQL database.
Going one step further, Human-gpDB is not only linked
to other sources but it also comes with some analysis
features to make the data integration part more useful.
Therefore, Human-gpDB comes with domain architecture
analysis, protein–protein/protein–chemical interactions
and pathway enrichment that will be explained in detail
in the ‘Utility and Discussion’ section below.
Implementation details
All the results are delivered to the user through a web ap-
plication. The database was implemented in mySQL where-
as for the graphical user interface (GUI), the HTML
language was used. The dynamic parts of the interface, as
for example the auto-complete forms and the advanced
search capabilities, are supported by Javascript. The com-
munication between the GUI and the database to extract
information from Human-gpDB was achieved with the use
of CGI scripts and all the calculations were performed using
Perl. The entire application is set up behind an apache web
server. The pop-up window that provides links to external
or internal data sources was implemented with the help of
the Overlib library. For the visualization, the Arena3D
standalone Java application (35) was used to support the
projections of large-scale networks whereas for smaller net-
works the Medusa Java applet (36) visualization tool was
used. Figure 1 shows an overview of Human-gpDB web
application.
Visualization
The visualization module in Human-gpDB was designed in
such a way, in order to give maximum flexibility to the user
to visualize the interactions between different knowledge
domains (GPCRs, G-proteins, effectors, drugs related to
GPCRs, drugs related to G-proteins and drugs related to
effectors) at different levels (depths) by taking advantage
of the hierarchical categories of GPCRs, G-proteins and
effectors.
Medusa, a 2D visualization tool (36), was used to graph-
ically visualize interaction partner bioentities such as pro-
teins or drugs as they come from the DrugBank, MATADOR
and AKS2 for each of the GPCR, G-protein and effector
proteins. The newer version of Medusa tool that supports
the current version of Human-gpDB is now more interactive
and many layout algorithms are implemented that make
the networks much more informative and the extraction
of the biological knowledge easier. Like Arena3D,
Medusa comes with a set of layout algorithms that are
able to minimize the crossovers between the nodes and
make the network visually simpler. Medusa is currently
provided as a java applet.
To show either the whole network consisting of drugs,
GPCRs, G-proteins, effector proteins and their interactions
or some large scale sub-networks, the Arena3D standalone
visualization tool (35) was used. According to Arena3D,
drugs, GPCRs, G-protein and effectors were separated
onto four different layers following a multi-layer graph
concept, a stack of 2D networks. Arena3D among others
currently comes with a clustering layout algorithm that is
able to visualize very efficiently predefined distinct clusters.
The separation of the clusters is done by placing the nodes
that belong to the same cluster together either in 2D or 3D
groups. The rich color scheme helps the user to immediately
recognize which node belongs to which cluster since nodes
that belong to the same cluster are colored similarly. Taking
advantage of this functionality, GPCRs, G-proteins and ef-
fectors were clustered individually onto their different
layers into families and subfamilies according to their prop-
erties as mentioned in the previous section, whereas drugs
were not clustered. Arena3D is highly interactive and gives
the opportunity to the user to isolate either individual,or a
set of, connections that reaches his interests for a more
focused research. Users can visually highlight and observe
patterns that can be easier processed by the user. Such an
example could be the answer to a question like whether a
protein targets a specific protein family or not. In this ver-
sion of Human-gpDB, pre-generated input files for the
interaction networks are available for download and can
be used as input files for the Arena3D application, since it is
currently available as a standalone application only and not
as a web based tool.
To visually show the domain structure, a static HTML
view was implemented. For the pathway visualization, the
KEGG schemas are given as they come from the KEGG data-
base. The parts of the pathways that the proteins of the
Human-gpDB are involved in are then highlighted to allow
the users to easier mark and distinguish the signal transi-
tion paths that each protein gets involved in. This function-
ality is also a strong point of Human-gpDB since researchers
can immediately see the influence of a specific protein on a
pathway.
Utility and discussion
Browse section
In this section, information about the three distinct cate-
gories according to the protein type is presented. These are
.............................................................................................................................................................................................................................................................................................
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category of proteins is further sub-divided into classes,
families, sub-families hierarchically. One can easily navigate
the results by choosing the respective category and then by
following the ‘+’ (expand) and the ‘’ (collapse) button to
navigate through the different levels of the hierarchy. Once
the user fully expands these categories and goes to the
lowest levels that contain the proteins, s/he can see some
information about these proteins like the name, the
description, the gene names, hyper links to UniProt and
links to the relevant entry page, a summary sheet and
visualization module (node level).
Entry page. The entry page of each protein contains
information about the class, the family, the subfamily
that each protein belongs to according to the IUPHAR (2)
classification, the sequence and a variety of cross references
to various available databases like the UniProt, EMBL,
InterPro, PRODOM, GENEID, MIM, PRINTS and PFAM. In
the entry page, links about proteins that interact with a
selected protein in the form of a sorted list and link to
node level visualization module. Redirections to the litera-
ture (PubMed) that reveal the evidence of the recorded
interaction are also given, so that users can observe the
biological relevance of each connection and see where
the interaction comes from.
Summary sheet. It provides information about each in-
dividual protein coming from a vast variety of publicly
available databases. The collected information is further
Figure 1. Over view of Human-gpDB web application. (a) Backend of the application consisting of manually collected informa-
tion regarding GPCRs, G-proteins, effectors and their interactions as well as awide range of publicly available information for
each of these proteins stored in a MySQL database (‘Data Integration’ section for more details). (b) A CGI-Perl script handles the
communication between the client and the server and (c) provides a wide range of information as output to the user
(see ‘Utility’ section for more details). The system can be coupled with (d) a 2D visualization tool (Medusa) and a 3D visualization
tool (Arena3D), which allows the easy visualization of the relationships between GPCRs, G-Proteins, effectors and the drugs
(see ‘Visualization’ sections for more details).
.............................................................................................................................................................................................................................................................................................
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teins, domains, structural features, diseases, gene ontology
(GO), pathways, chemicals and orthology. The information
of each section can be further explored by giving to re-
searchers the opportunity to go deeper into the volume
of knowledge in a more efficient way. All the information
is presented under the same web page, which not only
makes the exploration easier but it also reduces dramatic-
ally the loss of time that someone needs to find the infor-
mation by browsing and querying the available databases.
For example, if one checks the information in the section
‘Proteins’, he can see that it comes from four resources;
these are ‘Ensembl Proteins’, ‘Entrez Proteins’, ‘RefSeq
Proteins’ and UniPort. The information in these four re-
sources related to the protein of interest is either comple-
mentary to each other or it provides additional evidence.
Furthermore, Dasty2 DAS client links are given, to present
many of the protein features. Simultaneously, a link to visu-
alization module is provided to visualize the interactions
between GPCRs, G-proteins and effectors graphically. In
contrast to the entry page, the summary sheet provides
to the user all the relevant information about how each
protein is linked to other bioentities like genes, structures,
diseases, pathways, domains, chemicals, etc. The links that
are provided were explained in a previous paragraph of
this section.
Visualization module. Human-gpDB provides a very
flexible visualization module, where a user can select know-
ledge domains of interest, level or depth and also the tool
in order to visualize the particular network of user’s choice.
The user may choose to include all types of molecules
(GPCRs, G-proteins, effectors, drugs related to GPCRs,
drugs related to G-proteins and drugs related to effectors)
in the network or some of them. Also the user can decide
the level/depth (Class, Family, Subfamily, Type and Node) in
which the visualization will be made. This feature is avail-
able for GPCRs, G-proteins, effectors, but not for drugs.
Two visualization tools are offered as options: Medusa
(36), for 2D representations, and Arena 3D (35), for 3D visu-
alization. Drugs are not classified and thus they appear as
individual nodes connected to the respective type of mol-
ecule (GPCRs, G-proteins and effectors). The main reason
for giving the possibility to visualize the interactions at
these levels is because otherwise the information gets over-
crowded and it becomes difficult to clearly see the informa-
tion. Arena3D software was chosen to overcome the
problem of the 2D space limitations for visualizing larger
scale networks. These networks consist of hundreds of
nodes and hundreds of connections. The main feature of
Arena3D is that it utilizes 3D space to project the data. Like
Medusa, it also comes with efficient algorithms to minimize
the crossovers between the connections so that the net-
work becomes more informative. The Arena3D tool was
used to visualize the interactions between Drugs, GPCRs,
G-proteins and effectors for any selected category and
any protein level. Simultaneously, the four different mol-
ecule categories were separated onto four different 2D
layers by following a multi-layered graph representation.
These are the Drug, the GPCR, the G-protein and the effect-
or layers. Arena3D does not only visualize the nodes and
the edges of the network but it can also very efficiently
visualize precalculated clusters, which in the case of
Human-gpDB, represent the subfamilies of the proteins
(see ‘Visualization’ section for more details).
Pop-up window. While a user navigates through the
data in the browse section, he/she may further answer
questions that refer to a set of proteins that belong to a
specific level of the hierarchy and not only to individual
ones. A researcher for example, might want to see some
information about the whole B or C class of the GPCRs or
the ‘Gamma-aminobutyric’ acid receptor subfamily. This
way, a user may explore the biological knowledge related
to each category and sub category by following the hyper-
links provided by a pop-up window after clicking on high-
lighted names. The information that a particular user may
retrieve about a set of proteins is explained below.
Knowledge from biological databases. Biological
information from different databases for all of the mem-
bers of the selected category and sub category are dis-
played in a table view. A variety of sorting choices is
provided so that researchers can sort the target proteins
according to their names, their description, the family,
the class or the subfamily that they belong to if any.
Domain architecture. A static comparative domain
architecture view in order to detect patterns and investi-
gate if the selected category possesses specific structural
features is provided. Domain information of each protein
was collected from the SMART database and a HTML based
visualization tool was developed, to display this know-
ledge. In this view, each protein is hyperlinked to the
SMART and ENSEMBL databases. Mouse actions over a spe-
cific domain allow the user to interact with the GUI inter-
actively and get further information about the selected
domain.
Pathway information. Each protein was mapped to
KEGG pathways in order to find which pathways are en-
riched for the selected category. The results are provided
in a tabular view accompanied by a KEGG pathway identi-
fier, a pathway name and a list of proteins involved in that
pathway. Each pathway is hyperlinked to a red flag, which
ultimately displays the pathway, with the proteins from the
selected category highlighted in red color.
.............................................................................................................................................................................................................................................................................................
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interactions. Information about protein–protein and
protein–chemical interactions are provided by the STITCH
database (37). The collection of this information was done
through the available API. The generated networks do not
only include proteins stored in Human-gpDB database but
also proteins that are recorded in the STITCH database.
These proteins do not necessarily belong to one of the
three categories of proteins that Human-gpDB holds. The
STITCH database (37) goes one step further by providing
interacting proteins that were found experimentally
besides proteins that co-occur in the literature. Together
with the variety of information that STITCH database
holds, this is the main reason why this tool was selected
to provide to the user the relevant protein–protein and
protein–chemical interaction networks.
Visualization. This feature of the pop-up window redir-
ects the user to the Visualization module referring to the
particular level of the tree [see Visualization module
and ‘Visualization’ section (main manuscript) for more
details].
Blast search section
This feature of Human-gpDB database gives the opportun-
ity to the users to search for homologies by providing one
or more protein sequences in Fasta format. Wu-BLAST (38)
was used to align a given set of sequences against the se-
lected protein categories of Human-gpDB like for example
against the GPCR category. The user may provide the
advanced blast options in order to narrow down the
search results. The results are then grouped according to
their category and sorted by significance. Each result that is
found is then hyperlinked to an entry page, summary sheet
and node level visualization module. Here, the user can see
the alignments as well.
Advanced search section
This feature gives users the option to search the given fields
in the database. The user can enter any word in one or
more of the available boxes under the name: Gene/
Protein, Class, Family, Subfamily, Type, Description and
Function. Expressions in separate search fields are com-
bined with the AND operator, so every entry of the result
set will satisfy the expressions of all the search fields
the user has chosen. The user has the option to choose
whether the query will be performed against the
GPCRs, the G-proteins or the effectors included in the
database.
Results
The database currently holds information about 713 human
GPCRs, 36 human G-proteins and 99 human effectors.
The collection of information about the interactions be-
tween these molecules was done manually and the current
status of Human-gpDB reveals information about 1663 con-
nections between GPCRs and G-proteins and 1618 connec-
tions between G-proteins and effectors. GPCRs are
categorized in four classes. Table 1 shows the number of
families and subfamilies in each GPCR class, while Table 2
shows the distribution of GPCRs’ subfamilies based on the
number of Ga families with which they interact. G-proteins
are categorized in Ga,G b and Gg groups. Ga consists
of four respective families, as described initially in the
‘Backround’ section. From the 36 human G-proteins, 17
are characterized as Ga, 7 as Gb and 12 as Gg. Effectors
are categorized in 20 families, 29 subfamilies and 63 types
based on their biological function (Theodoropoulou, M.C.,
Table 1. Number of families and subfamilies in each GPCR
class
GPCRs’ Class No. of
GPCR
Families
No. of
GPCR
Subfamilies
Class A 55 640 (422 subfamilies
of olfactory receptor)
Class B 6 16
Class C 4 41 (29 subfamilies
of taste receptors)
Frizzled/Smoothened 2 11
Total 67 708
Class A is the largest and consists of 55 families and 640 subfami-
lies (422 subfamilies of olfactory receptors). Class B consists of
6 families and 16 subfamilies. Class C consists of 4 families and
41 subfamilies (29 subfamilies of taste receptors). Frizzled/
Smoothened class consists of 2 families and 11 subfamilies.
Table 2. Distribution of GPCR subfamilies based on the
number of Ga families with which they interact
Couples with No. of GPCRs’
Subfamilies
1G a family 623
2G a families 48
3G a families 15
All 4 Ga families 1
Unknown coupling 21
Total 708
One subfamily of GPCRs, the TSHR family, couples with members
of all four Ga families. Most of the GPCR subfamilies couple with
members of one Ga family (623 out of the 708 subfamilies of
GPCRs). Fifteen GPCR subfamilies couple with members from
3G a families, whereas 48 couple with members from 2 Ga
families. Twenty-one GPCR subfamilies do not have known
coupling.
.............................................................................................................................................................................................................................................................................................
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ation). The two most highly populated effectors’ families
are Ion Channels and Tubulins.
Visualization of the interactions between GPCRs,
G-proteins, effectors and drugs together with the rich
data integration part is one of the main features of
Human-gpDB. As described in the ‘Visualization’ section
Medusa application was used for 2D representation
of the networks of interactions. Arena3D was chosen for
3D and more efficient representation of either the whole
network of interactions or dense subparts of it. In order for
the user to evaluate the visualization tools offered, five
chosen different examples of visualization are given in
Figures 2–6. Medusa, which is a Java applet, offers the
user a first glance of the respective network. However
Medusa still has disadvantages compared to Arena3D
mainly due to the fact that the visualization it offers is in
2D so the space might be a limiting factor for larger or
dense networks.
Case study of human Prostanoid TP receptor’s
network of interactions
In order to demonstrate the utility of Human-gpDB, a case
study of human Prostanoid TP receptor’s network of inter-
actions (Figure 5) is presented. Human Prostanoid TP recep-
tor may couple with all four subfamilies (Gq,G 11,G 14 and
G15/16) of the Gq/11 family of G-proteins. These subfamilies
of G-proteins interact with 21 different types of effectors
belonging to 8 different families (Tubulins, PI3/PI4 kinases,
Phospholipases C, Ser/Thr protein kinases, TPR repeat pro-
teins, Tyr protein kinases, Guanine nucleotide exchange
factors and Ezrin-radixin-moesin-binding phosphoproteins).
For this specific receptor 23 different drugs exist. Using in-
formation from STITCH (37) about protein–protein and pro-
tein–chemical interactions, information regarding mostly
known natural or synthetic ligands is presented, comple-
menting the functional role of the receptor. Prostanoid
TP receptor is related with a bleeding disorder in cases of
defection of the receptor [information retrieved from
188070 entry of OMIM (26) database]. Regarding the
receptor’s participation in particular KEGG (30) pathways,
the receptor is involved in a calcium-signaling pathway
(hsa04020). Using the known coupling preferences of the
receptor, a researcher may relate the receptor with other
specific KEGG pathways (for example gap junction), in
which Gq/11G-proteins are known to participate. After
launching BLAST against Human-gpDB using human
Prostanoid TP receptor as query sequence, Prostanoid FR
receptor is the most similar entry. Prostanoid FR receptor
interacts with the same subfamilies of G-proteins, shares
four mutual ligands and agonists [comparison of the net-
works presented by STITCH (37)] and two mutual drugs
[comparison of the networks presented by Medusa (36)]
with Prostanoid TP receptor, and, both receptors
Figure 2. Visualization of human Bradykinin B2 receptor’s interactions (a) Arena3D Visualization: human Bradykinin B2 receptor
targets six different subfamilies of Ga G-Proteins belonging to Ga-q/11 and Ga-12/13 families. The G-Proteins are connected to
22 different types of effectors belonging to nine families. (b) Medusa 2D Visualization: human Bradykinin B2 receptor targets Ga
G-Proteins belonging to six distinct Ga subfamilies (Ga-q, Ga-11, Ga-14, Ga-15/16, Ga-12 and Ga-13). These Ga G-Proteins interact
with 22 types of effectors.
.............................................................................................................................................................................................................................................................................................
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the two receptors seem to share similar functions. Based
on that, a researcher may assume that chemicals that inter-
act with one of the receptors may also interact with the
other, leading to similar results (if a chemical is an agonist
for one receptor, probably it will also be for the other one
too). Therefore drugs known to affect the function of
Prostanoid TP receptor (for this receptor more drugs are
known) may also affect Prostanoid FR receptor too.
Prostanoid FR receptor is not yet related with any disease
(according to OMIM [26]), nevertheless there are 12 drugs
related with this receptor. One of these drugs is
Latanoprost, which is used for controlling the progression
of glaucoma or ocular hypertension by reducing intraocular
pressure and is a prostaglandin analogue. Based on the
known usage of this drug and also the fact that
Prostanoid FR receptor participates in the calcium-signaling
pathway, there are indications that this specific receptor
may be related with hypertension. As already shown, the
combination of different information retrieved from
Human-gpDB may help the researchers to design specific
experiments by which they will clarify the pathways in
which the receptors participate, propose a mechanism
for the specific disease in the case of Prostanoid TP
receptor, propose a relation between Prostanoid FR
receptor and hypertension and/or comprehend the side
effects of drugs.
Conclusions
Human-gpDB compared to the previous gpDB databases
(39,40) is now richer and focuses only on human GPCRs,
G-proteins and effectors. Human-gpDB is not simply
a gpDB subset, since it contains more recent data
(last update of gpDB was done in March 2008, whereas
all data of Human-gpDB were retrieved until December
2010), but it also contains new information concerning
the classification of GPCRs (11 new subfamilies were
added and all existing subfamilies are classified based
on the IUPHAR classification) and also contains interactions
between all molecules. It is fully integrated with external
data sources by bridging information that did not exist
in the previous versions (e.g. drugs and chemicals) and
it now comes with a new user-friendly environment
supported by advanced visualization techniques. The inter-
face makes the navigation friendlier, the exploration of
information more efficient and the extraction of new
knowledge easier. Human-gpDB database was built to
provide a simple but yet a powerful tool for researchers
in the life sciences field as it integrates a current, careful
collection of human GPCRs, G-proteins, effectors
and their interactions. Human-gpDB uses advanced visual-
ization techniques to make the volume of data more
informative and the advanced data integration
techniques make Human-gpDB a unique tool, a reference
Figure 3. Visualization of human Dopamine D5 receptor’s interactions. (a) Arena3D Visualization: Human Dopamine D5 receptor
targets two Ga-s G-Proteins. The G-Proteins are connected to 12 types of effectors belonging to four specific families. These are:
Adenylate cyclases, Regulators of G-Protein signaling, Tyr protein kinases and tubulins. (b) Medusa 2D Visualization: human
dopamine D5 receptor targets Ga-s G-Proteins, which interact with the following four families of effectors: Adenylate cyclases,
Regulators of G-Protein signaling, Tyr protein kinases and tubulins.
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.............................................................................................................................................................................................................................................................................................Figure 4. Visualization of human Rhodopsin receptors’ interactions. (a) Arena3D Visualization: Human Rhodopsin receptor tar-
gets three Ga G-Proteins that belong to the Ga-t subfamily. The three G-Proteins interact with five effectors belonging to the
Rhodopsin-sensitive cGMP-specific PDEases subfamily and more specifically to Phosphodiesterase 6 type of effectors. (b) Medusa
2D Visualization: the Rhodopsin subfamily of the Opsin/Rhodopsin family of the Class A of the GPCRs interacts with the Ga-t
subfamily of the G-Proteins which interact with the Rhodopsin-sensitive cGMP-specific PDEases effectors’ subfamily.
Figure 5. Visualization of human Prostanoid TP receptor’s interactions (drugs included). (a) Arena3D Visualization: Human
Prostanoid TP receptor protein of Class A GPCR family targets four Ga G-Proteins that belong to Gq/11 family. The G-Proteins
are connected to effectors proteins belonging to eight specific families. For this specific receptor 23 different drugs exist.
(b) Medusa 2D Visualization: Human Prostanoid TP receptor protein targets Ga G-Proteins that belong to Gq/11 family. These
G-Proteins interact with 11 different subfamilies of effectors. For this specific receptor 23 different drugs exist.
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the areas of chemical and drug discovery for human dis-
eases. In the future, the expansion of the current version
of the database for other organisms starting from
the ones that are evolutionarily closer to Humans
is essential.
Availability and requirements
Currently, two Human-gpDB servers are set up, one
running at EMBL (http://schneider.embl.de/human_gpdb)
and the other running at the Department of Cell Biology
and Biophysics of the University of Athens (http://
bioinformatics.biol.uoa.gr/human_gpdb/). Both servers
hold the same copy of the Human-gpDB database.
Concerning the linking to Human-gpDB from external
sources, other databases can link to our database by
using, for example, the following URLs: http://schneider
.embl.de/cgi-bin/human_gpdb.cgi?search=P21918 or http://
schneider.embl.de/cgi-bin/human_gpdb.cgi?search=
DRD5_HUMAN, based on Uniprot ID or Accession Number.
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